| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 4.728 | 35.781 | 49.684 | 51.694 | 44.877 | 9.645 | 4.382 | 14.486 |
| Total Income - EUR | - | - | 4.728 | 35.781 | 49.684 | 51.694 | 44.877 | 11.607 | 4.382 | 14.507 |
| Total Expenses - EUR | - | - | 14 | 5.404 | 7.150 | 13.663 | 4.535 | 2.379 | 1.562 | 3.567 |
| Gross Profit/Loss - EUR | - | - | 4.714 | 30.377 | 42.535 | 38.031 | 40.343 | 9.228 | 2.820 | 10.940 |
| Net Profit/Loss - EUR | - | - | 4.573 | 29.304 | 41.044 | 36.653 | 38.996 | 8.945 | 2.303 | 9.370 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Seb Diab Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.146 | 887 |
| Current Assets | - | - | 4.769 | 29.744 | 42.207 | 52.183 | 39.124 | 8.993 | 3.066 | 8.820 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 1.698 | 8.775 | 352 | 0 | 798 | -9.082 | 1.194 |
| Cash | - | - | 4.769 | 28.047 | 33.433 | 51.831 | 39.124 | 8.195 | 12.148 | 7.626 |
| Shareholders Funds | - | - | 4.616 | 29.355 | 41.095 | 36.703 | 39.045 | 8.993 | 2.352 | 9.436 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 153 | 389 | 1.113 | 15.481 | 79 | 0 | 1.860 | 421 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Seb Diab Medical Srl